Publication | Closed Access

Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway

InflammationFibrosisMolecular PhysiologyHepatologyCcl4-induced Hepatic FibrosisMedicineLiver PhysiologyPathologyHepatotoxicityLiver DiseaseHepatology FibrosisPharmacologyDrug-induced Liver InjuryCell SignalingPpar-γ ExpressionPi3k/akt Pathway